Thyroid hormone (T 3 ) is essential to normal brain development. Previously, we have shown that T 3 induces cerebellar astrocyte proliferation. This effect is accompanied by alteration in glial fibrillary acidic protein (GFAP) and fibronectin organization. In the present study, we report that the C6 glioma cell line, which expresses GFAP and is classified as an undifferentiated astrocytic cell type, is a target for T 3 action. The C6 monolayers were treated with 50 nM T 3 for 3 days, after which the cells were maintained for 2 days without medium changes. In C6 cells, T 3 induced the expression of proteins of 107, 73 and 62 kDa. The hormone also up-regulated protein bands of 100 (+50%), 37 (+50%) and 25.5 kDa (+50%) and down-regulated proteins of 94 (-100%), 86.5 (-100%), 68 (-100%), 60 (-100%), 54 (-33%), 51 (-33%) and 43.5 kDa (-33%). We suggest, on the basis of molecular mass, that the 54-, 51-and 43.5-kDa proteins could be the cytoskeletal proteins vimentin, GFAP and actin, respectively. The down-regulation of these proteins may be involved in the effects of thyroid hormone on C6 differentiation.
The importance of thyroid hormone (T 3 ) for normal development of the central nervous system is well documented. T 3 deficiency during the early stages of brain development produces severe mental retardation in both animals and humans (1) . It is known that during rat brain development, astrocytes are target cells for thyroid hormones (2, 3) . Thus, neonatal hypothyroidism results in an increased number of astrocytes in rat cerebellum and hyperthyroidism produces the opposite effect (2) . Thyroid hormone regulates the transition between radial glia and mature astrocytes in the basal forebrain and hippocampus (3) . In vitro, thyroid hormone induces the phosphorylation of specific proteins in astrocytes (4) . The presence of thyroid hormone receptor isoforms has been demonstrated in cultured type 1 and type 2 astrocytes (5). We have previously demonstrated that T 3 induces the synthesis and release of growth factors by astrocytes. The growth factors secreted by cerebral hemisphere astrocytes promote morphological differentiation in cells derived from cerebral hemispheres of normal and hypothyroid newborn rats. In contrast, the growth factors secreted by cerebellar astrocytes induce proliferation in astrocytes from normal neonatal cerebellum, accompanied by reorganization of glial fibrillary acidic protein (GFAP) filaments without changes in total GFAP amount (6) (7) (8) .
The rat glioma cell line C6, which was cloned from a chemically induced rat brain tumor, was classified as an undifferentiated astrocytic cell type (9) . Ortiz-Caro and colleagues (10) demonstrated the presence of nuclear T 3 binding capacity in C6 glioma cells and it has been reported that human glioma cell lines transport thyroid hormone through the plasma membrane (11) . The C6 glioma cell line has been used as an in vitro model for the study of glial cell properties. Thus, C6 cells provide means of studying the effects of thyroid hormone on tumors of glial origin.
Alterations in the response of specific brain proteins to thyroid hormone are well documented (12) . However, the precise mechanisms by which T 3 regulates the expression of target genes involved in brain development remain uncertain. The alteration in cellular proteins could be important for the effects of thyroid hormone on cellular differentiation. The objective of the present study was to determine the regulation of cell protein expression in rat C6 glioma cells by thyroid hormone.
The C6 cell line was grown in the presence of Dulbecco's modified Eagle's medium (DMEM, Sigma Chemical Co., St. Louis, MO) supplemented with 10% fetal calf serum (FCS). The cultures were incubated at 37 o C in a humidified 5% CO 2 and 95% air atmosphere. After confluence, the cells were treated with 50 nM 3-3'-5 triiodo-L-thyronine (T 3 , Sigma) for 3 days, with the T 3 medium changed after days 1 and 2. The T 3 was dissolved in FCS-free DMEM. Control cultures were maintained in DMEM without FCS during treatment. These cultures were then maintained for 2 days without medium changes. The cells were harvested, treated with trypsin, and lysed by successive freezing and thawing. The total proteins extracted from the cells were analyzed by SDS-PAGE 10% acrylamide gels according to Laemmli (13) . Fifty micrograms of protein per sample was loaded in each lane and stained with Coomassie blue.
The effect of thyroid hormone on protein expression in C6 cells was demonstrated experimentally (Figure 1 and Table 1 ). T 3 induced the expression of protein bands with molecular weights of 107, 73 and 62 kDa, that were absent in untreated C6 cultures. The expression of proteins of 73 and 62 kDa was more evident on the basis of the amount of stained protein. We also observed a slight increase in protein bands with molecular weights of 37 and 25.5 kDa and a strong enhancement in a protein of 100 kDa after the hormone treatment ( Figure 1 and Table 1 ).
However, after T 3 treatment the intensity of protein bands of 94, 86.5, 68, 60, 54, 51 and 43.5 kDa was reduced. The most significant effect was observed with the 68-and 60-kDa proteins ( Figure 1 and Table 1 ). The 51-and 54-kDa proteins may be intermediate filament proteins GFAP and vimentin based on their relative molecular masses (14, 15) . The 43.5-kDa protein could be the cytoskeletal protein, actin (16) .
The rat glioma cell line C6 was shown to express the intermediate filament proteins GFAP and vimentin (15) . The expression of GFAP was the principal criterion used to 
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classify this cell line as an undifferentiated astrocytic cell type. However, the expression of GFAP depends on specific culture conditions, indicating that this cell line represents a heterogeneous population (15, 17) . In addition, vimentin expression was reported to be present in the majority of C6 cells (15) .
In our experiments, the 51-and 54-kDa proteins, which were increased in control C6 cultures, may correspond to GFAP and vimentin subunits, respectively. Thyroid deficiency in early life reduces both the density and process length of the GFAP-labeled astrocytes in the rat parietal cortex and hippocampal formation (18) . On the other hand, neonatal thyroid hormone treatment results in a premature disappearance of vimentin-immunoreactive radial glia and a premature appearance of GFAP-immunoreactive astrocytes in the basal forebrain and hippocampus (3). Previously, we confirmed reports that astrocytes cultured from neonatal rat cerebellum proliferate after thyroid hormone treatment. This effect was accompanied by reorganization of GFAP filaments that were spread in the cytoplasm of astrocytes and became organized around the cell nucleus after T 3 treatment (7). In those experiments, we observed that total GFAP expression was not changed (8) . Thus, thyroid hormone seems to control many aspects of astrocyte differentiation. We suggest that T 3 may regulate C6 glioma metabolism similarly to cerebellar astrocytes. T 3 may induce C6 cells to proliferate and the regulation in vimentin and GFAP expression could be involved in this event. This hypothesis is currently under investigation in our laboratory.
Recent reports have shown that thyroid hormones modulate the biogenesis and assembly of actin (16, 19, 20) . Faivre-Sarrailh and colleagues (19) showed an increase in actin mRNA content in the hypothyroid brain relative to that of normal brain. Paul and Taken together, these data indicate that the C6 glioma cell line was responsive to thyroid hormone. In our experimental system, T 3 controlled the expression of C6 proteins. However, the hormone regulated these proteins differently. We observed that T 3 -treated C6 cells induced the expression of 107-, 73-and 62-kDa proteins. T 3 -treated C6 cells up-regulated the proteins of 100, 37 and 25.5 kDa and down-regulated the proteins of 94, 86.5, 68, 60, 54, 51 and 43.5 kDa. We suggest that the 54-, 51-and 43.5-kDa proteins could be vimentin, GFAP and actin, respectively. The down-regulation of these proteins may be involved in the effects of thyroid hormone on C6 differentiation.
